Wayfinder: May Edition
No images? Click here
DEA Reclassifying Marijuana
The United States Department of Health and Human Services (HHS) analyzed scientific research of cannabis to compose data revealing if cannabis encompassed medical/health benefits that should be acknowledged at the Federal level. Through their findings, they suggested to the DEA around August of last year (2023) that this drug should be recognized for its medical benefits at the Federal level which would consist of rescheduling it through the Controlled Substances Act, from a Schedule I which consists of drugs such as heroin that provide no medical use, and have a high potential for abuse, to a Schedule III which includes drugs such as Tylenol with Codeine that do provide medical use and have a moderate to low potential for abuse.
2024 WORKPLACE DRUG TESTING TRENDS REPORT RELEASED
Since 1988 Quest Diagnostics, the world’s leading provider of diagnostic information, releases their Drug Testing Index™ (DTI). This report examines drug test results from both the general workforce and federally mandated, safety-sensitive workforce (e.g., commercial drivers and airline pilots regulated by the U.S. Department of Transportation) to identify drug use trends.
Released May 15, the 2024 Drug Testing IndexTM examines nearly 9.8 million workforce drug tests conducted by Quest Diagnostics in 2023 and provides a comprehensive analysis of workplace drug trends.
On May 23, the House Agriculture Committee approved an amendment to the 2024 Farm Bill proposed by Representative Mary Miller (R-IL-15th). This amendment redefines hemp to exclude semi-synthetic cannabinoids that mimic the effects of delta-9 THC, such as delta-8 THC, delta-10 THC, and THC-O.
Please note - this is NOT a done deal but it does mark a significant initial step in the legislative journey for the Farm Bill to become law.
Promoting Mental Health in the Workplace: Tips for Employers during Mental Health Awareness Month
May is Mental Health Awareness Month, a crucial time to reflect on the mental well-being of employees. At Working Partners®, we understand that a drug-free workplace goes hand-in-hand with a mentally healthy workforce. Here are some tips for employers to support their employees' mental health.
DEADLINE APPROACHING
Private Sector DFSP Application & Safety Management Self-Assessment Due May 31st!
Private employers interested in the Drug-Free Safety Program and Transitional Work Bonus Program must file an application by May 31 for the program year beginning July 1, 2024.
Got questions? Visit our DFSP Help Zone or give us a call!
